Kringle Pharma, Inc. (TYO:4884)
Japan flag Japan · Delayed Price · Currency is JPY
510.00
-64.00 (-11.15%)
Nov 18, 2026, 10:50 AM JST

Kringle Pharma Financials Overview

Millions JPY. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Revenue
442442728069391
Revenue Growth
513.89%513.89%-10.00%15.94%-82.35%35.29%
Gross Profit
371371728069303
Operating Income
-814-814-909-817-889-426
Net Income
-813-813-916-756-854-331
Earnings Per Share
-105.23-105.23-133.88-118.14-158.44-68.16
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Net Cash (Debt)
1,6811,6811,6192,3132,1362,756
Net Cash Growth
3.83%3.83%-30.00%8.29%-22.50%28.97%
Net Cash Per Share
217.58217.58236.63361.45396.27567.55
Cash & Investments
1,6811,6811,6192,3132,1362,756

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Operating Cash Flow
-563-563-755-661-68915
Free Cash Flow
-563-563-755-661-68915
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Gross Margin
83.94%83.94%100.00%100.00%100.00%77.49%
Operating Margin
-184.16%-184.16%-1262.50%-1021.25%-1288.41%-108.95%
Pretax Margin
-183.71%-183.71%-1270.83%-943.75%-1236.23%-84.40%
Profit Margin
-183.94%-183.94%-1272.22%-945.00%-1237.68%-84.66%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
PS Ratio
10.899.5043.8772.0062.586.19